Trademarkia Logo

Australia

AU$
Trademark Search
RETHINK T2D

View On IPO.GOV.AU

RETHINK T2D
Registered: Registered/protected

Last updated on 21 Sept 2017

Owner Info

Intarcia Therapeutics, Inc. a Delaware corporation

One Marina Park Drive

Suite 1300, UNITED STATES OF AMERICA

Serial Number

1813594 filed on 5 Dec 2016

Correspondent

Davies Collison Cave Pty Ltd

Level 4,

7 Macquarie Place,

Sydney, NSW, 2000 AUSTRALIA

RETHINK T2D

Classification Information

Class [041]
Development and dissemination of educational materials of others in the fields of diabetes, drug delivery technologies and administration of pharmaceu Read More

Class [044]
Medical information services, namely, providing information on the topics of diabetes and the diagnosis, treatment and management therapies relating t Read More

Mark Details

Serial Number

1813594

Registered On

5 Dec 2016

Renewal On

5 Dec 2026

Mark Type

WORD

Priority Claim (Convention Details)

Date

6 Jun 2016

Mark Type

US

Legal History

Show more

Status DateAction Taken
21st Sept 2017IP Right Registration Published
14th Sept 2017Register Trade Mark
14th Sept 2017Application Status
6th Jul 2017IP Right Acceptance Published
28th Jun 2017Clear Examination report approved
28th Jun 2017User Created Notice correspondence sent
28th Jun 2017Application Accepted correspondence sent
1st Jun 2017Exam Response
24th Feb 2017Amend Name/Address
14th Feb 2017Amendment to Application/Registration